ES2046189T3 - Derivados de dihidropiridina y composiciones de los mismos. - Google Patents

Derivados de dihidropiridina y composiciones de los mismos.

Info

Publication number
ES2046189T3
ES2046189T3 ES198787112302T ES87112302T ES2046189T3 ES 2046189 T3 ES2046189 T3 ES 2046189T3 ES 198787112302 T ES198787112302 T ES 198787112302T ES 87112302 T ES87112302 T ES 87112302T ES 2046189 T3 ES2046189 T3 ES 2046189T3
Authority
ES
Spain
Prior art keywords
derivatives
dihydropyridine
compositions
salts
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787112302T
Other languages
English (en)
Inventor
Atsuyuki Ashimori
Taizo N 22 Heights Higashiyama Nishi-Iru Ono
Yoshihisa Inoue
Chikara Fukaya
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of ES2046189T3 publication Critical patent/ES2046189T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCION ES PROPORCIONAR DERIVADOS DE DIHIDROPIRIDINA DE SUS SALES DE ADICION DE ACIDOS QUE TIENEN ACTIVIDADES FARMACOLOGICAS AUN MAS EXCELENTES.
ES198787112302T 1986-08-27 1987-08-25 Derivados de dihidropiridina y composiciones de los mismos. Expired - Lifetime ES2046189T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61200849 1986-08-27
JP25307786 1986-10-23

Publications (1)

Publication Number Publication Date
ES2046189T3 true ES2046189T3 (es) 1994-02-01

Family

ID=26512428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787112302T Expired - Lifetime ES2046189T3 (es) 1986-08-27 1987-08-25 Derivados de dihidropiridina y composiciones de los mismos.

Country Status (5)

Country Link
EP (1) EP0257616B1 (es)
JP (1) JPH0686429B2 (es)
KR (1) KR950003923B1 (es)
DE (1) DE3782378T2 (es)
ES (1) ES2046189T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725750B2 (ja) * 1987-12-18 1995-03-22 富士レビオ株式会社 １，４‐ジヒドロピリジン誘導体
ES2143453T3 (es) * 1988-05-19 2000-05-16 Yoshitomi Pharmaceutical Uso de derivados de dihidropiridina para la profilaxis o el tratamiento de trastornos de la circulacion cerebral.
US5286869A (en) * 1988-12-15 1994-02-15 Fujirebio Kabushiki Kaisha 1,4-dihydropyridine derivatives
JP2838282B2 (ja) * 1988-12-29 1998-12-16 吉富製薬株式会社 血管攣縮治療剤
JPH03141257A (ja) * 1989-10-26 1991-06-17 Green Cross Corp:The ジヒドロピリジン誘導体
ES2119748T3 (es) * 1990-03-23 1998-10-16 Yoshitomi Pharmaceutical Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
EP0463407B1 (en) * 1990-06-25 2002-02-13 Mitsubishi Pharma Corporation Use of dihydropyridins in cardiotonic pharmaceutical compositions
CA2138297A1 (en) * 1993-04-19 1994-10-27 Yoshitomi Pharmaceutical Industries Ltd. Novel pharmaceutical use of dihydropyridine derivative
CA2147762A1 (en) * 1993-08-25 1995-03-02 Hiroshi Shinyama Circulatory disorder improving agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
EP0097821B1 (en) * 1982-06-03 1988-07-13 Pierrel S.p.A. Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them
IL77843A (en) * 1985-02-11 1989-07-31 Syntex Inc Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR950003923B1 (ko) 1995-04-20
KR880002828A (ko) 1988-05-11
EP0257616A3 (en) 1989-01-11
JPH0686429B2 (ja) 1994-11-02
EP0257616B1 (en) 1992-10-28
EP0257616A2 (en) 1988-03-02
DE3782378T2 (de) 1993-03-11
JPS63225356A (ja) 1988-09-20
DE3782378D1 (de) 1992-12-03

Similar Documents

Publication Publication Date Title
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2110003T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
ES2095380T3 (es) Derivados de indano-2-carboxialquilo sustituidos en la posicion 2 utiles como inhibidores de la encefalinasa y la eca.
ES2114870T3 (es) Nuevos derivados de mercaptoacetilamida utiles como inhibidores de encefalinasa y eca.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
ES2074916T3 (es) Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos.
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
ES2093732T3 (es) Nuevos derivados de erucilo, brasidilo y nervonilo.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES2046189T3 (es) Derivados de dihidropiridina y composiciones de los mismos.
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
ES2182090T3 (es) Nuevos derivados de pirrol.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 257616

Country of ref document: ES